The obvious priority is immediate discontinuation of any further topical corticosteroid use. Protection and support of the impaired skin barrier is another priority. Eliminating harsh skin regimens or products will be necessary to minimize potential for further purpura or trauma, skin sensitivity, and potential infection. Steroid Atrophy   is often permanent, though if caught soon enough and the topical corticosteroid discontinued in time, the degree of damage may be arrested or slightly improve. However, while the accompanying Telangectasias may improve marginally, the Striae is permanent and irreversible. 
Vaginal dryness and vaginal atrophy are common complaints in postmenopausal women. While these conditions do not produce serious consequences, they are a source of significant discomfort for many women. Hormone treatments are available that are very effective in reducing vaginal dryness, but whether or not to use hormone therapy is an individual decision that must consider the inherent risks and benefits of the treatment along with each woman's own medical history. Women with only mild symptoms may experience relief by using vaginal moisturizing agents and/or lubricants during sexual intercourse.
Early warning signs of skin atrophy include tension or tightness in the skin, pain, pitting, dryness and a papery texture or appearance, and increased visibility of blood vessels in the skin. The face is often the first place people notice the problem, because the skin there is more sensitive and also more visible. Patients can meet with a dermatologist to explore possible causes and talk about potential treatment options, including medications or changes to a skincare regimen like using gentler soaps and being more aggressive about moisturizing the skin.